(CercleFinance.com) – Deutsche Bank announced on Tuesday that it had initiated coverage of bioMérieux with a price target of 121 euros, welcoming the group’s flattering track record in terms of profitable growth.
Deutsche therefore says it expects average annual growth in turnover of 7% over the period 2023-2028 and of 11% in Ebit, performances superior to those of its market and its competitors.
This dynamism, he explains, should be supported by the extension of the offer towards new specialties, by an already solid product portfolio and by the quality of the management team.
In view of these catalysts and its attractive positioning in niche segments, the intermediary estimates that its valuation is currently attractive based on a 2025 PER of 22x.
Copyright © 2024 CercleFinance.com. All rights reserved.
The information and analyzes distributed by Cercle Finance only constitute a decision-making aid for investors. Cercle Finance cannot be held responsible directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional advisor before making any investment. This indicative information does not in any way constitute an inducement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends using the buttons below.
